|Infinity Pharmaceuticals Inc -- USA Stock|| |
USD 2.70 0.11 4.25%
Infinity Pharmaceuticals holds performance score of 14 on a scale of zero to a hundred. The company retains Market Volatility (i.e. Beta) of -0.3867 which attests that as returns on market increase, returns on owning Infinity Pharmaceuticals are expected to decrease at a much smaller rate. During bear market, Infinity Pharmaceuticals is likely to outperform the market.. Although it is essential to pay attention to Infinity Pharmaceuticals
current price history, it is also good to be reasonable about what you can actually do with equity current price movements. Macroaxis philosophy towards determining future performance of any stock is to look not only at its past charts but also at the business as a whole, including all fundamental and technical indicators
. To evaluate if Infinity Pharmaceuticals expected return of 1.9371 will be sustainable into the future, we have found twenty-one different technical indicators
which can help you to check if the expected returns are sustainable. Use Infinity Pharmaceuticals Inc Treynor Ratio
, and the relationship
between Standard Deviation
and Downside Variance
to analyze future returns on Infinity Pharmaceuticals Inc.
Infinity Pharmaceuticals Relative Risk vs. Return Landscape
If you would invest 186.00
in Infinity Pharmaceuticals Inc on February 15, 2018
and sell it today you would earn a total of 73.00
from holding Infinity Pharmaceuticals Inc or generate 39.25%
return on investment over 30
days. Infinity Pharmaceuticals Inc is currenly generating 1.9371% of daily expected returns and assumes 8.8644% risk (volatility on return distribution) over the 30 days horizon. In different words, 82% of equities are less volatile than Infinity Pharmaceuticals Inc and 64% of traded equity instruments are projected to make higher returns than the company over the 30 days investment horizon.
Daily Expected Return (%)
Given the investment horizon of 30 days, Infinity Pharmaceuticals Inc is expected to generate 9.27 times more return on investment than the market. However, the company is 9.27 times more volatile than its market benchmark. It trades about 0.22 of its potential returns per unit of risk. The DOW is currently generating roughly -0.05 per unit of risk.
Based on recorded statements Infinity Pharmaceuticals Inc has Operating Margin of -789.3%. This is 2299.82% higher than that of the Healthcare sector, and significantly lower than that of Pharmaceutical Products
industry, The Operating Margin for all stocks is 7134.65% higher than the company.
A good Operating Margin is required for a company to be able to pay for its fixed costs or pay out its debt which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against firm's competitors.
Infinity Pharmaceuticals Daily Price Distribution
The median price of Infinity Pharmaceuticals for the period between Thu, Feb 15, 2018 and Sat, Mar 17, 2018 is 2.07 with a coefficient of variation of 16.32. The daily time series for the period is distributed with a sample standard deviation of 0.36, arithmetic mean of 2.19, and mean deviation of 0.33. The Stock received some media coverage during the period.